FDA Clearance Tracker · DEN130032
XPERT MTB/RIF ASSAY
Last checked: Nov 20, 2026Latest source record: Jul 25, 2013 (this decision)Source: openFDAMethods & limitations
Decided
Jul 25, 2013
De Novo granted
Time to decision
44 days
Received Jun 11, 2013. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN130032
- Device name
- XPERT MTB/RIF ASSAY
- Applicant
- Cepheid
- Applicant location
- Sunnyvale, CA
- Received
- Jun 11, 2013
- Decided
- Jul 25, 2013
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.3373
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN130032
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Cepheid
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262971 · Decided Oct 30, 2026 · 65 days after receipt
Device type: Multiplex Nucleic Acid Detection System For Biothreat Agents (QVR) · Laboratory Medicine & Pathology
K263333 · Decided Oct 22, 2026 · 30 days after receipt
Device type: Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents (QOF) · Laboratory Medicine & Pathology
K263120 · Decided Oct 2, 2026 · 28 days after receipt
Device type: Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents (QOF) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.